SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
Vertex reports first quarter 2024 financial results
Vertex is pleased to release its 2023 Corporate Responsibility Report
We’re pleased to announce significant progress across our pain program
Vertex enters into agreement to acquire Alpine Immune Sciences
We’re advancing our investigational treatment for APOL1-mediated kidney disease (AMKD) into Phase 3 of clinical development
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Find a Vertex clinical trial
Volunteers who participate in clinical trials
help make new medicines a reality.
Featured Stories